Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
02/2010
02/17/2010CN101648931A Method for preparing 3-(2,3-dihydrobenzfuran-5-radical)-metacetonic acid
02/17/2010CN101648930A 3,4,5-multi-substistuted-methylene-gamma-butyrolactone derivative, synthesis method thereof and purpose thereof
02/17/2010CN101648929A Lignanoid-like compound contained in cabo and preparation method and application thereof
02/16/2010US7662976 Triptolide derivatives for modulation of apoptosis and immunosuppression
02/16/2010US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
02/16/2010US7662965 Anabaseine derivatives, pharmaceutical compositions and method of use thereof
02/16/2010US7662851 Use of specific cyklolignans
02/16/2010US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid
02/16/2010US7662805 Mixture of antidepressant such as serotonine receptor antagonist, with acetylsalicylic acid
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2394270C Process for the co-production of aliphatic diols and cyclic ethers
02/16/2010CA2385081C Carboxylic acid compound and a medicament comprising it
02/16/2010CA2346082C Tricyclic .delta.3-piperidines as pharmaceuticals
02/11/2010WO2010015613A1 Organic compounds
02/11/2010US20100036139 Process for the preparation of benzofuran-2-carboxamides
02/11/2010US20100035980 Antiparasitic agents
02/11/2010US20100035948 Furanone compounds and lactam analogues thereof
02/11/2010US20100035932 Novel formyl peptide receptor like 1 agonists that induce macrophage tumor necrosis factor alpha and computational structure-activity relationship analysis of thereof
02/11/2010US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof
02/11/2010DE102006006379B4 Verwendung einer Vorrichtung zur gleichmäßigen Verteilung von Stoffen Use of a device for uniform distribution of substances
02/11/2010CA2732932A1 Organic compounds
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010EP1686121B1 Liquid cyclohexane-tricarboxylic acid anhydride
02/10/2010EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents
02/10/2010CN101646664A Furanone compounds and lactam analogues thereof
02/10/2010CN101643462A Hapten and antigen of nitrofurans and preparation method and application thereof
02/10/2010CN101643461A Method for preparing aminoethyl thioether
02/10/2010CN101643460A Production method of furfural with high purification rate and special apparatus therewith
02/10/2010CN100588655C Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
02/10/2010CN100588653C Compound with proteasome inhibition function and its preparing method and application
02/10/2010CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof
02/09/2010US7659412 Benzofuran derivatives useful for treating hyper-proliferative disorders
02/09/2010US7659308 Concentricolide and its derivatives, process for preparing them, pharmaceutical composition comprising the same and its use
02/09/2010US7659307 Heterocyclic carboxamides and their use as fungicides
02/09/2010CA2413061C Serine protease inhibitors
02/09/2010CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
02/09/2010CA2291065C Raf kinase inhibitors
02/09/2010CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/04/2010WO2010013620A1 Process for producing phthalic anhydride derivative
02/04/2010WO2010012795A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
02/04/2010US20100029968 Asymmetric reaction catalyst and method for preparing optically active compound using the same
02/04/2010US20100029955 Catalyst system and method for gas phase oxidation using an upstream layer
02/04/2010US20100029953 Phenyltetraene-based nonlinear optical chromophores
02/04/2010US20100029952 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems
02/04/2010US20100029786 Flavor improving agent, and food and drink containing the same
02/04/2010US20100029761 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
02/04/2010US20100029752 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
02/04/2010US20100029745 Derivatives of substituted 3-phenyl-1-(phenylthienyl)propan-1-ones and of 3-phenyl-1-(phenylfuranyl) propan-1-ones, preparation and use
02/04/2010US20100029670 Organic compounds
02/04/2010US20100029640 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
02/04/2010US20100029614 Spirocyclic heterocyclic derivatives and methods of their use
02/04/2010US20100028474 Sesame seed derived pigments
02/04/2010US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents
02/04/2010CA2731200A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
02/03/2010EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
02/03/2010CN101638406A Phthalide preparing method
02/03/2010CN101638405A High-purity salvianolic acid B, preparation method and application thereof
02/03/2010CN101638404A High-purity salvianolic acid B and preparation method and application thereof
02/03/2010CN101638403A High-purity salvianolic acid B and preparation method and application thereof
02/03/2010CN101638402A Online quality monitoring method for salvianolic acid B production
02/03/2010CN101638401A Method for preparing high-purity danshinolic acid B
02/03/2010CN101638400A Method for recovering tetrahydrofuran from Grignard reaction waste residue of magnesium chloride
02/03/2010CN100586941C Separation purification process for producing 3-O-alkyl ascorbic acid ether by one-step method from vitamin C
02/03/2010CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase
02/02/2010US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
02/02/2010US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases
02/02/2010CA2440528C Ionic liquids as selective additives for the separation of close-boiling or azeotropic mixtures
02/02/2010CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor
02/02/2010CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
01/2010
01/28/2010WO2010010924A1 Anthracene derivative, and organic electroluminescence element comprising same
01/28/2010WO2010010165A1 Synthesis routes to 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
01/28/2010WO2010009632A1 Antifouling furan-2-one derivatives
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors
01/28/2010WO2008135746A3 Natural bioactive compounds
01/28/2010US20100022785 catalytic partial oxidation of o-xylene and naphthalene with a gas comprising oxygen in a plant containing two or more reaction zones cooled with a coolant, coolant entering first reaction zone has a 20 degree C. higher temperature of the coolant entering second reaction zone; improved yield
01/28/2010US20100022773 Apoptosis promoters
01/28/2010US20100022605 N-hydroxyamide derivatives possessing antibacterial activity
01/28/2010US20100022594 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome
01/28/2010US20100022527 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases
01/28/2010CA2731262A1 Synthesis routes to 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
01/28/2010CA2730265A1 Series of skin-whitening (lightening) compounds
01/27/2010EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity
01/27/2010EP1303503B1 Aniline derivatives
01/27/2010CN101633651A Method for preparing furfuraldehyde directly from water washing substances of steam explosion through acidless autocatalysis
01/27/2010CN101633650A Novel compounds, pharmaceutical compositions containing same, and methods of use for same
01/27/2010CN101633649A Preparation method of gamma-valerolactone spice and application method in cigarettes
01/27/2010CN100584841C Andrographolide derivatives and application of the same in pharmacy
01/27/2010CN100584838C Eremophilone lactones acid natural product and application thereof
01/27/2010CN100584837C Hydroxy stilbene kind compound and its preparation method and application
01/27/2010CN100584819C Substituted 4-aminocyclohexanol derivatives
01/27/2010CN100584459C Application of dehydroabietylamine thiourea catalyst in synthesizing chiral compound with high-antipodism both-hand control
01/27/2010CN100584323C Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
01/26/2010US7652172 Expeditious synthesis of DPD
01/26/2010US7652168 Synthesis of taxol enhancers
01/26/2010US7652155 Diamine derivative, production process therefor and antioxidant
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof
01/26/2010US7652002 9-aminoacyl tetracycline compounds and methods of use thereof